Join to View Full Profile
7200 Cambridge StreetSuite A07.113Houston, TX 77030
Phone+1 713-798-3484
Dr. Sukumar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Senthil Sukumar is a hematology specialist based in Houston, TX. He completed his medical education at the University of Missouri Kansas City School of Medicine in 2015, followed by an internal medicine residency at the University of Texas Southwestern Medical Center (2015-2018) and a fellowship in hematology and medical oncology at Ohio State University Hospital (2019-2022). He served as a Clinical Fellow at The OSUCCC - James. Dr. Sukumar has contributed to the field through multiple publications, including studies on thrombomodulin as a biomarker in TTP and the use of recombinant ADAMTS13 in pregnancy, with several of his works being cited by other academic publications.
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2019 - 2022
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2015 - 2018
University of Missouri Kansas City School of MedicineClass of 2015
Certifications & Licensure
TX State Medical License 2017 - 2027
OH State Medical License 2019 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Thrombotic Thrombocytopenic Purpura (TTP) Survivors Exhibit Impaired Stress Perfusion on Cardiac MRI.Senthil Sukumar, Leah Danish, Yuchi Han, Spero Cataland
American Journal of Hematology. 2025-05-03 - Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incidence of Venous Thromboembolism in Older Adults.Seyedmohammad Saadatagah, Rock Bum Kim, Senthil Sukumar, Md Mesbah Uddin, Aaron R Folsom
Journal of Thrombosis and Haemostasis. 2025-04-17 - Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic Purpura.Aaron B Boothby, Michael D Evans, Shangbin Yang, Senthil Sukumar, James G Scott
Journal of Clinical Medicine. 2025-01-22
Press Mentions
Increased Mortality Rate Seen in Survivors of Thrombotic Thrombocytopenic PurpuraDecember 7th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
